Prediction Model for the Risk of Developing Foot Ulcers in Diabetes
NCT07307183 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100000
Last updated 2025-12-29
Summary
Introduction Foot ulcers in diabetes mellitus (DM) are a common and serious complication that can lead to infection, amputation, and increased mortality. Early identification of patients at high risk is crucial in order to implement preventive measures at an early stage. The number of people with DM is increasing globally, from 540 million in 2021 to an estimated 780 million by 2045. Foot ulcers cause considerable suffering for the individual and entail substantial costs for the healthcare system.
Despite national guidelines recommending regular, structured foot examinations and risk classification to assess the risk of developing foot ulcers, current risk models do not take into account the complex interactions between risk factors and socioeconomic factors such as marital status, level of education, and place of residence.
Data-driven advances and artificial intelligence (AI) offer new opportunities to refine risk identification, but their use in predicting the risk of diabetic foot ulcers remains limited. The need for foot screening is considerable. In Sweden, there are approximately 600,000 patients with DM, and half of them live with an increased risk due to nerve damage in the feet. This means that, based on risk level, around 300,000 patients in Sweden may require preventive interventions, including medical foot care, customised footwear, and access to specialist care for those with foot ulcers. Improved preventive efforts are emphasised in the person-centred and integrated care pathway for people with diabetes at high risk of foot ulcers. However, accurate identification of foot ulcer risk is currently lacking.
Prevention leads not only to good quality of life for the individual but also to reduced healthcare costs. Estimates by Ragnarsson Tennvall show that a hard-to-heal ulcer costs approximately SEK 100,000 per year, while an amputation costs around SEK 300,000-500,000. Given a prevalence of foot ulcers of 5% among patients with diabetes, the annual cost of ulcer care amounts to SEK 3 billion. In addition, there are costs of approximately SEK 750 million for amputations, according to data from the quality register SwedAmp.
The aim of the study is to develop, test, and validate prediction models (statistical and AI-based) to identify patients with DM who are at risk of developing foot ulcers. The models will be based on retrospective electronic health record data from primary care in the Västra Götaland Region (VGR), as well as data from Statistics Sweden (SCB) concerning demographic factors such as marital status, level of education, occupation, and place of residence.
Methods The study has two methodological approaches: AI-based modelling and statistical modelling.
AI-based approach Machine learning models will be developed to predict patients at risk of developing diabetic foot ulcers. The models will be trained using cross-validation on a large dataset in which variables will be iteratively excluded. Conformal prediction will be used to quantify uncertainty in patient-level predictions. The resulting models will be analysed to identify the strongest predictors and will be compared with classical statistical modelling and findings from the literature.
Steps in AI modelling:
Data extraction: Electronic health record data from primary care in VGR, supplemented with sociodemographic data from SCB.
Data processing: Use of, among other variables, diagnostic codes (ICD-10), healthcare interventions (KVÅ codes), visit types, visit frequency, ECG parameters, and free-text data to construct predictors.
Model development: Prediction models will be developed and trained using cross-validation. Measures of uncertainty will be generated using conformal prediction.
Validation: A separate cohort will be used to test model performance (sensitivity, specificity, positive predictive value \[PPV\]).
Interpretation: The models will be reviewed for transparency and clinical interpretability in collaboration with patient representatives, clinicians, and researchers.
The results of the statistical and AI-based models will be compared with regard to their respective strengths and weaknesses.
Statistical modelling Two populations will be analysed: patients with diabetes without foot ulcers and patients with diabetes with foot ulcers. Co-variation and causal relationships between risk factors and foot ulcers will be identified. A model describing causal pathways leading to ulcer development will be developed, and its certainty and uncertainty will be analysed.
Conditions
- Diabete Mellitus
Sponsors & Collaborators
-
Sahlgrenska University Hospital
lead OTHER
Principal Investigators
-
Ulla Hellstrand Tang, Associate Professor · The Department of Prosthetics & Orthotics at the Department for Biomedical Engineering and Medical Physics at Sahlgrenska University Hospital, Gothenburg, Sweden
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-01-30
- Primary Completion
- 2027-12-30
- Completion
- 2027-12-30
Countries
- Sweden
Study Locations
More Related Trials
-
Remote Monitoring of the Diabetic Foot to Prevent Re-Ulceration
NCT06053047 ·Status: TERMINATED ·Phase: NA
-
Comprehensive Assistance and Resources for Effective Diabetic Foot Navigation
NCT07223268 ·Status: RECRUITING ·Phase: NA
-
Characteristics of Diabetic Foot Ulcer Patients
NCT07188337 ·Status: RECRUITING
-
Multifactorial Strategies for the Prevention of the Risks of Ulceration in Patients Affected by Diabetic Foot (DARE-DiaFoot)
NCT07021222 ·Status: RECRUITING ·Phase: NA
-
Shockwave Therapy of Chronic Diabetic Foot Ulcers
NCT02251418 ·Status: COMPLETED ·Phase: NA
-
Pressure and Diabetic Foot
NCT03213093 ·Status: RECRUITING ·Phase: NA
-
FeetSee Thermal Images Collection Protocol in Diabetes Patients
NCT07300163 ·Status: NOT_YET_RECRUITING
-
Diabetic Foot Ulcer Prevention System (DFUPS) - Part 2
NCT02579070 ·Status: COMPLETED ·Phase: NA
-
Impaired Wound Healing in Diabetic Foot Ulceration
NCT00739323 ·Status: COMPLETED
-
The Role of Extrinsic Foot Muscles Chances in Determining the Risk of Diabetic Foot Ulcer
NCT06736210 ·Status: COMPLETED ·Phase: NA
-
Hyperspectral Imaging to Assess and Predict Diabetic Foot Ulcers
NCT00617916 ·Status: COMPLETED
-
Evaluating a Lifestyle Intervention to Prevent Recurrence of Diabetic Foot Ulcers
NCT06487780 ·Status: RECRUITING ·Phase: NA
-
Environmental Factors on DFUs Incidence - a Mixed-mode Survey
NCT05464524 ·Status: COMPLETED
-
Improving DFU Outcomes: Early Detection of Foot Ulcers Using Novel Technology
NCT05968924 ·Status: COMPLETED ·Phase: NA
-
A Comparative Efficacy Study of DermaPure™ to Treat Diabetic Foot Ulcers
NCT02081352 ·Status: UNKNOWN ·Phase: PHASE4
-
DFC 004 Biomarkers for Active Diabetic Foot Ulcers
NCT06104969 ·Status: RECRUITING
-
Evaluation of the Clinical Efficacy and Feasibility of Digital Foot Care Intervention Strategies With Different Intensities in the Prevention of Diabetic Foot Ulcers.
NCT07185048 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Remote Temperature and Visual Monitoring To Help Manage Diabetic Foot Ulcers
NCT06782386 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Tele-homecare Service for Diabetic Foot Patients (Risk 0, Risk 1 and Risk 2 Level): Testing and Validation of Dedicated APPs and Artificial Intelligence Solutions
NCT05829811 ·Status: NOT_YET_RECRUITING
-
Efficacy and Safety Study of DERMAGEN® vs Conventional Treatment to Treat Diabetic Neuropathic Foot Ulcer
NCT00521937 ·Status: UNKNOWN ·Phase: PHASE3
-
Three-dimensional Measurements of Diabetic Foot Ulcers
NCT02423850 ·Status: COMPLETED
-
3D Camera - Telemedical Foot Ulcer Treatment
NCT01870934 ·Status: UNKNOWN
-
Treatment of Diabetic Foot Ulcers With AUP1602-C
NCT04281992 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Dose Finding Study of Topically Applied I-020201 as an Adjunct to Good Standard-of-care in Patients With Chronic Diabetic Foot Ulcers
NCT00915486 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Subjects With Diabetic Foot Ulcer (DFU)
NCT03153007 ·Status: COMPLETED